MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE
|
Back to Search Results |
|
Model Number 8637-20 |
Device Problems
Insufficient Flow or Under Infusion (2182); Infusion or Flow Problem (2964)
|
Patient Problem
Pain (1994)
|
Event Date 05/17/2022 |
Event Type
malfunction
|
Event Description
|
Information was received from multiple sources (manufacturer representative, healthcare provider) regarding a patient who was receiv ing unknown drug via an implantable pump for non-malignant pain.It was reported that the expected volume was around 3 ml and actual volume collected was over 9 ml.The patient reported that some pain has returned.There were no known factors that may have led or contributed to the issue.Cap (catheter access port) procedure was completed in the office but aspiration was unsuccessful.The physician ordered a ct scan and now waiting on results from the scan.It was unknown if the issue was resolved at the time of report.The patient's weight and medical history were asked but unknown.The patient's status at the time of report was alive, no injury.Additional information received from a company representative (rep) reported that the results from the imaging have not been reported to the medtronic team at this time.The physician wanted to get the scan done and check for a discrepancy at the next refill.
|
|
Manufacturer Narrative
|
Concomitant medical products: product id: 8780, serial#: (b)(4), implanted: (b)(6) 2019, product type: catheter.Other relevant device(s) are: product id: 8780, serial/lot #: (b)(4), ubd: 27-aug-2020, udi#: (b)(4).If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Continuation of d10: product id 8780 lot# serial# (b)(6) implanted: (b)(6)2019.Explanted: product type catheter medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information received from the healthcare provider (hcp) via a company representative reported that the hcp made an adjustment to the dose of the personal therapy manager (ptm) and requested that the patient try to use the ptm.They would like to further observe if the patient was getting relief from the bolus.The hcp is going to continue to monitor the reservoir volume.Currently, the patient is getting some relief from the pump.
|
|
Event Description
|
Additional information received reported the company representative would be seeing the patient tomorrow.Per the reporter, the patient had come in for a refill and the healthcare provider had noted a 6ml volume discrepancy.The patient had a dye study and had declined a therapeutic bolus that day.The patient had been instructed to have a ct scan but the reporter did not know the results yet.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|